Controladora Vuela (VLRS) director exercises 120,850 RSUs, gains 64,200 new

Q: What insider transactions did VLRS director Joaquin Alberto Palomo Deneke report?

He reported three equity-related transactions . On April 28, 2026, he exercised 120,850 RSUs into Series A shares. On April 24, 2026, he received a new grant of 64,200 RSUs. These moves reflect compensation-related equity activity , not open-market trades.

Q: What RSU grant did the VLRS director receive on April 24, 2026?

On April 24, 2026, he received a grant of 64,200 Restricted Securities Units (RSUs) . Each RSU represents a contingent right to receive one Series A share. These RSUs will vest on April 24, 2027 and have no expiration date according to footnotes.

Q: What RSUs did the VLRS director exercise on April 28, 2026?

He exercised 120,850 RSUs on April 28, 2026, receiving 120,850 Series A shares. Footnotes explain these RSUs were originally granted on April 28, 2025 and vested one year later, turning into fully owned common shares upon exercise.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Controladora Vuela Compania de Aviacion director Joaquin Alberto Palomo Deneke exercised equity awards and received a new grant. On April 28, 2026, he exercised 120,850 Restricted Securities Units (RSUs), receiving the same number of Series A shares of common stock, bringing his direct holdings to 222,710 shares. This was an exercise or conversion of derivative securities, not an open‑market purchase or sale.

The RSUs exercised on April 28, 2026 were originally granted on April 28, 2025 and vested that day. Separately, on April 24, 2026, he was granted 64,200 RSUs that will vest on April 24, 2027. Each RSU represents a contingent right to receive one Series A share, and the RSUs have no expiration date.

Insider Trade Summary

120,850 shares exercised/converted

Mixed 3 txns

Insider Palomo Deneke Joaquin Alberto

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Securities Units (BoDIP)	120,850	$0.00	--
Exercise	Series A shares of common stock	120,850	$0.00	--
Grant/Award	Restricted Securities Units (BoDIP)	64,200	$0.00	--

Holdings After Transaction: Restricted Securities Units (BoDIP) — 0 shares (Direct, null); Series A shares of common stock — 222,710 shares (Direct, null)

Footnotes (1)

The Restricted Securities Units ("RSUs") were granted on April 28, 2025 and vest on April 28, 2026. The RSUs have no expiration date. Shares owned through American Depositary Shares ("ADSs"). Each ADS representing ten (10) Certificados de Participacion Ordinarios (CPOs). Each CPO representing the economic interest in one (1) share of Series A shares of common stock. Each RSU represents a contingent right to receive on Series A share of common stock. The RSUs were granted on April 24, 2026 and will vest on April 24, 2027. The RSUs have no expiration date.

Key Figures

RSUs exercised: 120,850 units Shares held after exercise: 222,710 shares New RSU grant: 64,200 units +2 more

5 metrics

RSUs exercised 120,850 units Exercised into Series A shares on April 28, 2026

Shares held after exercise 222,710 shares Direct Series A share ownership after April 28, 2026

New RSU grant 64,200 units Granted April 24, 2026, vesting April 24, 2027

Prior RSU grant vesting April 28, 2026 RSUs granted April 28, 2025 vested and were exercised

ADS to share structure 1 ADS = 10 CPOs = 10 Series A shares ADSs each represent ten CPOs, each tied to one share

Key Terms

Restricted Securities Units ("RSUs"), American Depositary Shares ("ADSs"), Certificados de Participacion Ordinarios (CPOs), Series A shares of common stock, +1 more

5 terms

Restricted Securities Units ("RSUs") financial

"The Restricted Securities Units ("RSUs") were granted on April 28, 2025"

American Depositary Shares ("ADSs") financial

"Shares owned through American Depositary Shares ("ADSs"). Each ADS representing ten (10)"

American Depositary Shares (ADSs) are U.S.-listed certificates issued by a bank that represent ownership of a specified number of a foreign company’s ordinary shares, letting U.S. investors buy and sell those interests in U.S. dollars on American markets. They matter because they make investing in overseas companies as easy as buying a domestic stock—streamlining currency, settlement, and recordkeeping—while still exposing investors to foreign-market risks like exchange rates and local regulations.

Certificados de Participacion Ordinarios (CPOs) financial

"Each ADS representing ten (10) Certificados de Participacion Ordinarios (CPOs)."

Series A shares of common stock financial

"Each CPO representing the economic interest in one (1) share of Series A shares of common stock."

contingent right financial

"Each RSU represents a contingent right to receive on Series A share of common stock."

Form 4 Insider Transactions: What Each Field Means →

04/28/2026 - 04:03 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Palomo Deneke Joaquin Alberto

(Last)

(First)

(Middle)

AV. ANTONIO DOVALI JAIME NO. 70

13 FL, TWR B, COLONIA ZEDEC SANTA FE

(Street)

MEXICO CITY

01210

(City)

(State)

(Zip)

MEXICO

(Country)

2. Issuer Name and Ticker or Trading Symbol
Controladora Vuela Compania de Aviacion, S.A.B. de C.V. [ VLRS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Series A shares of common stock	04/28/2026		M⁽¹⁾		120,850⁽²⁾	A	⁽³⁾	222,710⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Securities Units (BoDIP)	⁽³⁾	04/24/2026		A		64,200		⁽⁴⁾	⁽⁴⁾	Series A shares of common stock	64,200	$0.00	64,200	D
Restricted Securities Units (BoDIP)	⁽³⁾	04/28/2026		M			120,850	⁽¹⁾	⁽¹⁾	Series A shares of common stock	120,850	$0.00	0	D

Explanation of Responses:

1. The Restricted Securities Units ("RSUs") were granted on April 28, 2025 and vest on April 28, 2026. The RSUs have no expiration date.

2. Shares owned through American Depositary Shares ("ADSs"). Each ADS representing ten (10) Certificados de Participacion Ordinarios (CPOs). Each CPO representing the economic interest in one (1) share of Series A shares of common stock.

3. Each RSU represents a contingent right to receive on Series A share of common stock.

4. The RSUs were granted on April 24, 2026 and will vest on April 24, 2027. The RSUs have no expiration date.

	/s/ Isela Cervantes Rodriguez, as Attorney-in-Fact, for Joaquin A. Palomo Deneke	04/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did VLRS director Joaquin Alberto Palomo Deneke report?

He reported three equity-related transactions. On April 28, 2026, he exercised 120,850 RSUs into Series A shares. On April 24, 2026, he received a new grant of 64,200 RSUs. These moves reflect compensation-related equity activity, not open-market trades.

How many VLRS shares does the director hold after these transactions?

Following the April 28, 2026 exercise, Joaquin Alberto Palomo Deneke directly holds 222,710 Series A shares of common stock. This figure reflects shares received from exercising 120,850 RSUs, as reported in the Form 4, and shows his post-transaction ownership position.

What RSU grant did the VLRS director receive on April 24, 2026?

On April 24, 2026, he received a grant of 64,200 Restricted Securities Units (RSUs). Each RSU represents a contingent right to receive one Series A share. These RSUs will vest on April 24, 2027 and have no expiration date according to footnotes.

What RSUs did the VLRS director exercise on April 28, 2026?

He exercised 120,850 RSUs on April 28, 2026, receiving 120,850 Series A shares. Footnotes explain these RSUs were originally granted on April 28, 2025 and vested one year later, turning into fully owned common shares upon exercise.

Do the RSUs and ADSs in the VLRS Form 4 affect how many shares the director controls?

Yes. Each RSU represents one Series A share upon vesting, and shares can be held through American Depositary Shares (ADSs). Each ADS represents ten CPOs, and each CPO represents the economic interest in one Series A share, linking depositary receipts to underlying equity.

Were any VLRS shares sold or bought on the open market in this Form 4?

No open-market buys or sells are reported. The filing shows derivative exercises and grants: RSUs were exercised into common shares, and a new RSU grant was awarded. All transactions are coded as compensation-related equity movements, not market purchases or sales.